Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Kathy Moscou"'
Transnational pharmacogovernance: emergent patterns in the jazz of pharmaceutical policy convergence
Publikováno v:
Globalization and Health, Vol 14, Iss 1, Pp 1-20 (2018)
Abstract Background As a transnational policy network, the International Council for Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) aligns international regulatory standards to address the pressures of
Externí odkaz:
https://doaj.org/article/4357573989bc48d697f3548531a07641
Transnational pharmacogovernance: emergent patterns in the jazz of pharmaceutical policy convergence
Publikováno v:
Globalization and Health, Vol 14, Iss 1, Pp 1-20 (2018)
Globalization and Health
Globalization and Health
Background As a transnational policy network, the International Council for Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) aligns international regulatory standards to address the pressures of globaliz
Autor:
Nada Abdel Rida, Abubakr A. Alfadl, Mukhtar Ansari, Yara Arafat, Saira Azhar, Zaheer-Ud-Din Babar, Gianluigi Casadei, Yu Fang, Ahmed I. Fathelrahman, Omotayo Fatokun, Mohamed Azmi Hassali, Saval Khanal, Jillian C. Kohler, Paola Minghetti, Mohamed Izham Mohamed Ibrahim, Kathy Moscou, Chin H. Ng, Tuan A. Nguyen, Lisa M. Nissen, Benson Njuguna, Guat See Ooi, Subish Palaian, Sonak Pastakia, Vibhu Paudyal, Arjun Poudel, Pathiyil Ravi Shankar, Elizabeth E. Roughead, Shane L. Scahill, Asrul A. Shafie, Dixon Thomas, Dan N. Tran, Dinesh K. Upadhyay, Albert I. Wertheimer, Zhi Yen Wong, Kangkang Yan, Kazeem B. Yusuff, Seeba Zachariah
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::edd2854d7eb10c9a15b171f32e6157dd
https://doi.org/10.1016/b978-0-12-811228-1.01002-5
https://doi.org/10.1016/b978-0-12-811228-1.01002-5
Autor:
Jillian Clare Kohler, Kathy Moscou
How national, state, and municipal governments establish priorities, make policy, and allocate resources are shaped by governance. Pharmacogovernance influences national and subnational policy choices (or lack thereof) for governing structures, polic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::48956878bed44e71043163840f3f067c
https://doi.org/10.1016/b978-0-12-811228-1.00024-8
https://doi.org/10.1016/b978-0-12-811228-1.00024-8
Autor:
Jillian Clare Kohler, Kathy Moscou
Publikováno v:
Globalization and Health
Background The Kenyan government has sought to address inadequacies in its National Pharmaceutical Policy and the Pharmacy and Poisons Board’s (PPB) medicines governance by engaging with global actors (e.g. the World Health Organization). Policy ac
Publikováno v:
Journal of Health Politics, Policy and Law. 38:545-571
The Canadian constitution divides the responsibility for pharmaceuticals between the federal and provincial governments. While the provincial governments are responsible for establishing public formularies, the majority of the safety and efficacy inf
Publikováno v:
Journal of Pharmaceutical Policy and Practice
Background This scoping review investigates the relationship between governance, pharmacovigilance, and Agencia Nacional de Vigilancia Sanitaria (ANVISA) in Brazil, which has authority over Brazil's national pharmaceutical policy, drug registration a
Autor:
Kathy Moscou, Karen Snipe
Specially designed to parallel the material in Pharmacology for Pharmacy Technicians, 2nd Edition, this helpful workbook provides in-depth study and review of the ASHP content requirements for pharmacology and anatomy and physiology. Its user-friendl
Autor:
Kathy Moscou, Karen Snipe
Updated drug information ensures you are familiar with the latest drug approvals and therapeutic considerations. Additional learning resources on the companion Evolve website include: Certification practice exam to better prepare you for the PTCB or
Publikováno v:
Social sciencemedicine (1982). 75(1)
Although international medicines regulators adopt a common system to assess the safety and efficacy of new drugs, pre-market evaluation is recognized as incomplete given the much larger post-market experience to follow. Adverse drug reactions contrib